NEW YORK -- Beststocksdaily, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Microsoft Corporation, Baidu, Apple, VIVUS.
There are several issues associated with Microsoft Corporation (NASDAQ:MSFT)’s Windows Phone 8 and the company is investigating them.
The two key issues seem to be email-sync problems and random phone reboots that are reportedly happening regardless of carrier choice, according to Mary Jo Foley from ZDNet.
How Should Investors Trade MSFT Now? Find Out Here http://beststocksdaily.com/p2/index.php?company=MSFT
Foley said that the HTC 8X that she had on loan saw the email client and Microsoft Account on the handset going into an endless loop of trying to resync and the phone even spontaneously rebooted one morning.
Tech Spot which did a quick check of Microsoft support forum saw that lots of others users ere reporting similar problems.
When the editor of Tech Spot contacted Microsoft, the company said that it was investigating reports of these incidents, suggesting that it must have been receiving a lot of complaints about it.
China's search engine Baidu.com, Inc. (ADR)(NASDAQ:BIDU) said on Wednesday it is raising $1.5 billion in two tranches via a bond sale to pay down debt and also to strengthen its war chest.
Will BIDU Rebound After The Recent Slump? Get Free Trend Analysis Here http://beststocksdaily.com/p2/index.php?company=BIDU
Kaiser Kuo, Baidu’s director of international communications, said that proceeds from the sale will be used for acquisitions both in China and abroad: “We want to be ready to invest opportunistically as good deals present themselves. We are not limiting ourselves to investments in the mobile sector, though mobile is certainly one of our priorities.”
Customers will no longer have to wait for their iPhone 5 to arrive as Apple Inc. (NASDAQ:AAPL) seems to have fixed the problem of short supply of the device.
Piper Jaffray's Gene Munster who has been keeping checks on the availability of the phone said that stocks had shown significant improvement over the past 10 days.
Is It The Right Time To Buy AAPL? Find Out Here http://beststocksdaily.com/p2/index.php?company=AAPL
"We believe," he concludes, "that within the next two weeks that customers will be able to purchase iPhone 5s at Apple Stores same day."
VIVUS, Inc. (NASDAQ:VVUS) shares soared 14% to $11.78 as In a Clinical Policy Bulletin revision dated November 20, 2012, Aetna (AET) specified criteria under which the insurer considers weight reduction medications as "medically necessary" for treatment of obesity. Aetna stated, "For members whose medical policies do not exclude weight reduction medications or services and supplies for or related to weight reduction programs, Aetna covers [the following] drugs under the medical benefit, not the pharmacy benefit."
Has VVUS Found The Bottom And Ready To Move Up? Find Out Here http://beststocksdaily.com/p2/index.php?company=VVUS
Among the medications that have been approved by the FDA for weight reduction which would be covered under its policy, Aetna listed Qsymia, marketed by VIVUS (VVUS), Belviq from Arena Pharmaceuticals (ARNA), Didrex from Pfizer's (PFE) Pharmacia unit, Roche's (RHHBY) Xenical, and GlaxoSmithKline's (GSK) Alli.
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA
Leave a comment...